Katharine J. Head
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katharine J. Head has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Nancy Grant Harrington
University of Kentucky, USA
17 shared publications - Gregory Zimet
Indiana University School of Medicine and Zimet Research Consulting LLC
15 shared publications - Monica L. Kasting
Department of Public Health, Purdue University, 812 W. State St, West Lafayette, IN, USA
8 shared publications Gregory D. Zimet
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA
6 shared publications- Katherine Ellen Ridley-Merriweather
IU Simon Comprehensive Cancer Center
4 shared publications - Melanie L. Kornides
School of Nursing, University of Pennsylvania, 418 Curie Blvd, Philadelphia, PA 19104, USA
4 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 22 (1) , 2734052
Health care providers’ perspectives on county-level barriers and facilitators to HPV vaccination: A socio-ecological approach (2022–2023)
Human papillomavirus (HPV) infection has been causally linked to multiple forms of cancer, including cervical, anal, vaginal, penile, and oropharyngeal cancers, as well as genital warts and recurre...
- 5 October 2026
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 22 (1) , 2734052
Open AccessHealth care providers’ perspectives on county-level barriers and facilitators to HPV vaccination: A socio-ecological approach (2022–2023)
Human papillomavirus (HPV) infection has been causally linked to multiple forms of cancer, including cervical, anal, vaginal, penile, and oropharyngeal cancers, as well as genital warts and recurre...
- Open Access
- 8 July 2026
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 22 (1) , 2698280
Shared clinical decision-making for vaccination: A view through the lens of mid-adult HPV vaccination
In October 2018, the U.S. Food and Drug Administration expanded approval of the 9-valent human papillomavirus vaccine (9vHPV) to adults ages 27 through 45 y.1 Subsequently, at their June 2019 meeti...
- 8 July 2026
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 22 (1) , 2698280
Open AccessShared clinical decision-making for vaccination: A view through the lens of mid-adult HPV vaccination
In October 2018, the U.S. Food and Drug Administration expanded approval of the 9-valent human papillomavirus vaccine (9vHPV) to adults ages 27 through 45 y.1 Subsequently, at their June 2019 meeti...
- Open Access
Correlates of Integrated Human Papillomavirus Vaccination and Cervical Cancer Screening Protection in U.S. Low-Income Women
Background/Objectives: In the United States, adult human papillomavirus (HPV) vaccination coverage remains low at 20–50%, depending on age, and cervical cancer (CC) screening rates range from 68 to 76%. Few studies have evaluated characteristics of women who are both HPV vaccinated and up to date (UTD) with screening as an integrated outcome. The purpose of the present study was to classify women into four prevention categories and examine factors associated with being double protected compared to unprotected. Methods: Data were gathered via an online survey from a sample of low-income women (household income < USD 50,000) provided by a research survey company (n = 719). Women were classified into four categories: vaccinated only, screened only, both vaccinated and screened (double protected), or neither (unprotected). Sociodemographic characteristics, healthcare access, and Health Belief Model constructs were assessed. Multivariable logistic regression compared women who were double protected with those unprotected (n = 274). Results: Most women were UTD with screening only (57.8%), while 15.5% were double protected and 22.6% were unprotected. Younger age (Odds Ratio [OR = 0.93; 95% Confidence Interval [CI]: 0.89, 0.98), having ≥1 medical visit in the past year (OR = 4.16; 95% CI: 1.74, 9.95), higher perceived CC risk (OR = 3.65; 95% CI: 1.41, 9.43), greater perceived benefits of CC screening (OR = 1.96; 95% CI: 1.45, 2.66), and higher HPV knowledge (OR = 1.09; 95% CI: 1.01, 1.17) were associated with higher odds of being double protected. Conclusions: A substantial proportion of low-income women lack comprehensive CC prevention. Integrated, bundled prevention strategies that simultaneously promote HPV vaccination and screening may be important to reduce CC disparities.
Open AccessCorrelates of Integrated Human Papillomavirus Vaccination and Cervical Cancer Screening Protection in U.S. Low-Income Women
Background/Objectives: In the United States, adult human papillomavirus (HPV) vaccination coverage remains low at 20–50%, depending on age, and cervical cancer (CC) screening rates range from 68 to 76%. Few studies have evaluated characteristics of women who are both HPV vaccinated and up to date (UTD) with screening as an integrated outcome. The purpose of the present study was to classify women into four prevention categories and examine factors associated with being double protected compared to unprotected. Methods: Data were gathered via an online survey from a sample of low-income women (household income < USD 50,000) provided by a research survey company (n = 719). Women were classified into four categories: vaccinated only, screened only, both vaccinated and screened (double protected), or neither (unprotected). Sociodemographic characteristics, healthcare access, and Health Belief Model constructs were assessed. Multivariable logistic regression compared women who were double protected with those unprotected (n = 274). Results: Most women were UTD with screening only (57.8%), while 15.5% were double protected and 22.6% were unprotected. Younger age (Odds Ratio [OR = 0.93; 95% Confidence Interval [CI]: 0.89, 0.98), having ≥1 medical visit in the past year (OR = 4.16; 95% CI: 1.74, 9.95), higher perceived CC risk (OR = 3.65; 95% CI: 1.41, 9.43), greater perceived benefits of CC screening (OR = 1.96; 95% CI: 1.45, 2.66), and higher HPV knowledge (OR = 1.09; 95% CI: 1.01, 1.17) were associated with higher odds of being double protected. Conclusions: A substantial proportion of low-income women lack comprehensive CC prevention. Integrated, bundled prevention strategies that simultaneously promote HPV vaccination and screening may be important to reduce CC disparities.
- 3 March 2026
- Published by Taylor & Francis
- p. 132-150
Grammar
This chapter addresses elements of grammar that have been studied for their persuasive effects. It reviews three classes of grammatical elements. First, it
- 3 March 2026
- Published by Taylor & Francis
- p. 132-150
Grammar
This chapter addresses elements of grammar that have been studied for their persuasive effects. It reviews three classes of grammatical elements. First, it
- 3 March 2026
- Published by Taylor & Francis
- p. 202-219
Audio
In today's media- and sound-rich environment, message designers can integrate audio elements into their messages to strive to enhance persuasive effects. In
- 3 March 2026
- Published by Taylor & Francis
- p. 202-219
Audio
In today's media- and sound-rich environment, message designers can integrate audio elements into their messages to strive to enhance persuasive effects. In
- 3 March 2026
- Published by Taylor & Francis
- p. 3-22
Conceptual and Methodological Issues
Chapter 1 covers conceptual and methodological issues foundational to persuasive message design. It offers a working definition of the term message and presents
- 3 March 2026
- Published by Taylor & Francis
- p. 3-22
Conceptual and Methodological Issues
Chapter 1 covers conceptual and methodological issues foundational to persuasive message design. It offers a working definition of the term message and presents
- 3 March 2026
- Published by Taylor & Francis
- p. 23-40
Theory
This chapter reviews multiple theories that can inform the content and structure of persuasive messages and reviews studies that applied the theories to guide
- 3 March 2026
- Published by Taylor & Francis
- p. 23-40
Theory
This chapter reviews multiple theories that can inform the content and structure of persuasive messages and reviews studies that applied the theories to guide
- 3 March 2026
- Published by Taylor & Francis
- p. 93-111
Framing
This chapter provides a review of approaches to message framing. It reviews conceptual issues in framing research and discusses the processes through which
- 3 March 2026
- Published by Taylor & Francis
- p. 93-111
Framing
This chapter provides a review of approaches to message framing. It reviews conceptual issues in framing research and discusses the processes through which
- 3 March 2026
- Published by Taylor & Francis
- p. 223-240
Message Development
This chapter covers the message development process. The first phase of message development involves doing initial groundwork on goal identification, audience
- 3 March 2026
- Published by Taylor & Francis
- p. 223-240
Message Development
This chapter covers the message development process. The first phase of message development involves doing initial groundwork on goal identification, audience
- 3 March 2026
- Published by Taylor & Francis
- p. 41-54
Audience, Source, Channel, Behavior
This chapter considers components of persuasive communication that are beyond the message but still relevant to effective persuasive message design. Guided by
- 3 March 2026
- Published by Taylor & Francis
- p. 41-54
Audience, Source, Channel, Behavior
This chapter considers components of persuasive communication that are beyond the message but still relevant to effective persuasive message design. Guided by